Direkt zum Inhalt
Merck
  • Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Bioorganic & medicinal chemistry letters (2009-04-11)
Shohei Hamada, Tae-Dong Kim, Takayoshi Suzuki, Yukihiro Itoh, Hiroki Tsumoto, Hidehiko Nakagawa, Ralf Janknecht, Naoki Miyata
ZUSAMMENFASSUNG

N-Oxalylglycine (NOG) derivatives were synthesized, and their inhibitory effect on histone lysine demethylase activity was evaluated. NOG and compound 1 inhibited histone lysine demethylases JMJD2A, 2C and 2D in enzyme assays, and their dimethyl ester prodrugs DMOG and 21 exerted histone lysine methylating activity in cellular assays.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
tert-Butylbromacetat, 98%
Sigma-Aldrich
Dimethylsuccinat, 98%, FG